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A B S T R A C T
Cytological criteria for the identification of glandular intraepithelial lesions (GIL) have not yet been fully described,
especially for the precursors of adenocarcinoma in situ (AIS), thus these lesions may frequently remain unrecognized. As
most patients diagnosed with AIS or mild to moderate GIL (grades I, II) are free from clinical symptoms, cytology has a
very responsible role in the detection of these lesions. The aim of the study was to achieve the most appropriate cytologic
diagnosis of intraepithelial lesions of endocervical columnar epithelium, analyzing the cytology findings in patients
with histologically verified AIS and GIL (I, II). The value of cytology in the detection and differential diagnosis was as-
sessed in 123 patients with definitive histologic diagnosis of glandular lesions (AIS, n=13; GIL I, n=11; and GIL II,
n=7), and glandular lesions associated with squamous component (AIS associated with cervical intraepithelial neopla-
sia (CIN) or invasive squamous cell carcinoma (SCC), n=58; GIL I or GIL II associated with CIN, n=28; and GIL asso-
ciated with microinvasive squamous carcinoma (MIC), n=6). In 95.1% of patients, lesions were detected by cytologic
analysis that indicated additional diagnostic procedure. In terms of differential diagnosis, cytology showed higher accu-
racy in predicting lesion severity vs. type of epithelial alteration (75.6% vs. 55.3%) and abnormalities of columnar epithe-
lium (95.7%; vs. 74.2%). The accuracy of cytology was higher in pure (AIS, 61.5% and GIL I, II, 22.2%) than in mixed le-
sions (25.9% and 20.6%). Continuous improvement in cervical specimens and cytodiagnostic skills, better understanding
of intraepithelial adenocarcinoma and precursors, and their inclusion in the classification of cytologic and histologic
findings are expected to upgrade the detection of these lesions, and to reduce the invasive cervical adenocarcinoma mor-
bidity and mortality.
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Introduction
The incidence of the cervix uteri adenocarcinoma has
been increasing for the last 20 years, especially in young
women1. The reasons for this rising trend include im-
proved diagnosis with more appropriate sampling and
better preparation techniques for both cytologic and
histologic analysis, better recognition of precursor le-
sions, changes in nomenclature, evolving methods of
treatment and improved understanding of the morpho-
logical features, having led to the development of criteria
for the diagnosis of early dysplastic lesions. Another rea-
son is the increasing prevalence of these lesions.
Although endocervical adenocarcinoma in situ (AIS)
is a well-known precursor of invasive adenocarcinoma,
there is no universally accepted precursor of AIS itself2,3.
Cervical cytologic screening has decreased the incidence
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of invasive squamous cell carcinomas (SCC) of the cervix
by detecting preinvasive lesions4. The morphological di-
agnostic criteria, which are well established for AIS5–10,
have not been universally accepted for borderline precur-
sor lesions, which have been termed endocervical dyspla-
sia6 or low grade glandular intraepithelial lesion (LGIL)11,
or glandular intraepithelial lesion (GIL grade I, II)12,
etc., yet there is an agreement that these lesions should
have some but not all features of AIS and need not to be
associated with inflammation13.
Some authors consider that cytology may not be reli-
able enough to detect pure AIS14, whereas others believe
that the usefulness of Pap findings in the detection of
glandular premalignant lesions may increase with im-
provement of the sampling technique and strict focusing
on glandular lesions during analysis, thus influencing
the adenocarcinoma morbidity and mortality15.
Cytological classification of cervical glandular
lesions in Croatia
In the NCI Bethesda 2001 cytologic classification16
squamous intraepithelial lesions (SIL) with identifiable
subgroups (low grade and high grade SIL) are recog-
nized, in contrast to glandular lesions where AIS precur-
sors are not identified. The Australian modification17 of
the 1988 Bethesda System (TBS)18 for glandular lesions
points better to the risk of the presence of high-grade ab-
normalities, thus resulting in more appropriate recom-
mendations and protocol. A uniform classification of cer-
vical cytology findings named Zagreb 200219 (Table 1),
i.e. a modification of the Zagreb 199020 and NCI Bethe-
sda System 2001 classifications16, is currently used in
Croatia. In Zagreb 2002 classification, like NCI Bethesda
System 2001, glandular lesions have been divided into
three categories: atypical glandular cells (AGC), adeno-
carcinoma in situ (AIS), and adenocarcinoma. In Zagreb
2002 AGC are divided into three subgroups, similarly
like in other studies17,21,22:
¿ favor reactive – cell alterations that are more pro-
nounced than benign reactive ones but quantita-
tively and qualitatively less pronounced than those
in intraepithelial lesions;
¿ favor intraepithelial – cell alterations of low to mod-
erate severity, without inflammatory cell changes,
and/or suspect of AIS, without definite criteria; and
¿ favor invasive – cell alterations suspect of invasive
lesion, where differential cytologic diagnosis cannot
be made, mostly due to poor specimen preparation.
The group of AIS requires definite criteria to be pres-
ent. The group of adenocarcinoma has not been modified
relative to previous classifications. For any group or sub-
group of abnormal glandular cells, it is crucial to identify
the origin of columnar epithelium whenever possible, as
it is of great importance for further diagnostic work-up
and therapeutic procedure23. At the end of the report, the
cytologist provides the clinician with instructions on how
to improve the quality of cervicovaginal smears, and with
guidelines on further procedures for a particular cyto-
logic finding. These instructions are in line with the cur-
rent diagnostic-therapeutic protocol in use in Croatia24.
In order to reach an as accurate and precise cytologic
diagnosis of intraepithelial lesions of endocervical colum-
nar epithelium as possible, the cytologic findings of pa-
tients with histologically verified AIS and mild to moder-
ate GIL were analyzed.
Materials and Methods
During the 1993–2007 period, the value of cytology in
the detection and differential diagnosis considering le-
sion severity and/or type of altered epithelium was as-
sessed in 123 patients with definitive histologic diagnosis
of glandular lesions (AIS, n=13; GIL I, n=11; GIL II,
n=7), glandular lesion associated with a squamous com-
ponent (AIS+ cervical intraepithelial neoplasm (CIN)/
SCC, n=58; GIL I/GIL II+CIN, n=28; and GIL+ micro-
invasive squamous carcinoma (MIC), n=6).
Cytologic features of intraepithelial glandular
lesions of the uterine cervix5–13,15,25–29
The cytomorphological criteria for the diagnosis of
AIS refer to changes in the architecture (sheet of cells,
strip, rosette, gland opening, feathering), and cells. Cell
size is uniform and enlarged. Cytoplasm is cyanophilic,
occasionally vacuolated. Nuclear size is uniform and usu-
ally enlarged. Nuclear shape is oval or round, uniform.
Mitotic figures are occasionally or, according to some au-
thors, regularly present (Figure 1).
However, cellular changes may frequently be less pro-
nounced than those in squamous lesions and are difficult
to observe unless architectural alterations call for atten-
tion. In mixed lesions, the glandular component may be
eclipsed in abnormal cell count and intensity by the
squamous component. Mild and moderate glandular intra-
epithelial lesions (dysplasia) have not been clearly de-
fined, while reproducibility of the cytologic and histologic
criteria for their identification has not been fully ex-
plored. Cellular alterations in GIL (grade I, II) are simi-
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Fig. 1. Large hyperchromatic group of crowded cells typical for
Adenocarcinoma in situ. Note the group of normal endocervical
cells in the right lower part of the picture. (Papanicolaou-stained
cervical scrape, ×100).
lar to but less pronounced than those in AIS. The type of
desquamation is also similar, only the columnar cells are
slightly packed showing a palisading pattern with mild
pseudostratification, nuclear overlapping is less pronoun-
ced, and also feathering and rosettes are seen. Cell size is
like that in normal findings or slightly enlarged. Nuclear
size within a cluster varies to a greater extent than in
AIS. The nucleus is round or oval, hyperchromasia is less
pronounced, chromatin is finely granular and evenly dis-
tributed, and nucleoli are small and round. Mitoses are
rare. Background is usually clean (Figures 2 and 3).
Results
Intraepithelial endocervical columnar lesions, with or
without intraepithelial or invasive squamous component,
were diagnosed in histology samples (78 biopsy speci-
mens, 82 excochleation specimens, 70 conization speci-
mens and 24 hysterectomy materials) from 123 patients
aged 22–73 (mean 39.89) years. The patients were di-
vided into two categories: group 1 including 71 patients
(mean age 39.69) histologically diagnosed as AIS or AIS
associated with (CIN) or SCC, and group 2 including 52
patients (mean age 40.15) histologically diagnosed as
mild or moderate glandular intraepithelial lesions with
squamous component (GIL I/GIL II+CIN, GIL+MIC) or
without it (GIL I, GIL II).
In group 1, cytologic findings indicated epithelial ab-
normality in 98.6% (70/71) of patients. Considering le-
sion severity, the cytologic and histologic diagnoses were
identical in 93% (66/71) of patients. The accuracy of cyto-
logic diagnosis according to lesion severity and type of
epithelium was 92.3% (12/13) for glandular lesions and
56.9% (33/58) for mixed lesions. On predicting the type of
epithelium involved, agreement between the cytologic
and histologic diagnosis was recorded in 61.5% (8/13) of
histologically pure (AIS) and 20.7% (12/58) of mixed le-
sions (AIS+CIN/SCC). The rate of cytologic identifica-
tion of abnormalities of a particular type of epithelium,
histologically diagnosed as either pure or mixed lesions,
was 92.3% (12/13) and 96.6% (56/58) for columnar and
squamous epithelium, respectively (Table 2).
In group 2, cytologic findings indicated epithelial ab-
normality in 90.4% (47/52) of patients. Considering le-
sion severity, the cytologic and histologic diagnoses were
identical in 80.8% (42/52) of patients. The accuracy of cy-
tologic diagnosis according to lesion severity and type of
epithelium was 61.1% (11/18) for glandular lesions and
35.3% (12/34) for mixed lesions.
On predicting the type of epithelium involved, agree-
ment between the cytologic and histologic diagnosis was
recorded in 22.2% (4/18) of histologically pure (GIL I)
and 20.6% (7/34) of mixed lesions (GIL I, II+CIN/MIC).
The rate of cytologic identification of abnormalities of a
particular type of epithelium, histologically diagnosed as
either pure or mixed lesions, was 61.1% (11/18) and 100%
(34/34) for columnar and squamous epithelium, respec-
tively (Table 3).
Discussion
Most patients diagnosed with GIL (grade I, II) and
AIS are free from clinical symptoms6, the portio is of nor-
mal macroscopic appearance and colposcopic images ha-
ve long been considered nonspecific6. Some authors state
that characteristic vascular changes are found in glandu-
lar lesions30. The lesion is detected by cytology on routine
smear sampling (Pap test)31–33 or by histology (on ECC,
biopsy specimen, conization specimen, loop excision, hys-
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Fig. 2. Crowded sheets of cells from glandular intraepithelial le-
sion grade 1. (Papanicolaou-stained cervical smear, ×100).
Fig. 3. Hyperchromatic group of crowded cells with scant cyto-
plasm and pseudosrtatification from glandular intraepithelial
lesion grade 2. (Papanicolaou-stained cervical smear, ×100).
TABLE 1
CYTOLOGICAL CLASSIFICATION OF GLANDULAR LESIONS:
ZAGREB 2002 CLASSIFICATION
Glandular cells:
Atypical glandular cells Site of origin:
Favor reactive change Endocervical
Favor intraepithelial lesion Endometrial
Favor neoplastic lesion Extrauterine
Adenocarcinoma in situ (AIS) Not specified
Adenocarcinoma Other
terectomy material) on examination for SIL or during
operative procedure for myoma32,33. Hence, cytology has
a very prominent and responsible role in the detection
and diagnosis of these lesions.
The cytologic diagnosis of AIS of endocervical colum-
nar epithelium as a separate entity was only included in
the NCI Bethesda System 2001 classification16, whereas
dysplasia of endocervical columnar epithelium as an AIS
precursor is still considered as a cytologically and histo-
logically inadequately defined entity13 and therefore has
not been included in the classification16. However, the
fact that AIS patients are older than women with squa-
mous CIS34 and that the reverse holds true for adeno-
carcinoma and SCC could imply that the progression of
GIL to AIS must be slower than the progression of CIN
lesions to CIS; in contrast, AIS should progress to adeno-
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TABLE 2
CYTOHISTOLOGIC CORRELATION OF EITHER PURE ADENOCARCINOMA IN SITU (AIS) OR A MIXED AIS AND SQUAMOUS
ABNORMALITY
Cytology n
Histology
Pure Mixed
AIS AIS + CIN AIS + SCC total
n (%) n n n (%)
AIS 9 8 (61.5) 1 1 (1.7)
AIS + CIN 15 1 (7.7) 12 2 14 (24.2)
AC 6 3 (23.1) 3 3 (85.2)
AC + CIN 2 2 2 (3.4)
AC + SCC 4 3 1 4 (6.9)
GIL + CIN 9 8 1 9 (15.6)
CIN 21 20 1 21 (36.2)
MIC 2 1 2 (3.4)
Abnormal 2 2 1 2 (3.4)
Inflammation 1 1 (7.7)
Total 71 13 (100.0) 52 6 58 (100.0)
% 100.0 18.3 81.7
AIS – adenocarcinoma in situ, CIN – cervical intraepithelial neoplasia, AC – adenocarcinoma, SCC – invasive squamous cell carcinoma,
MIC – microinvasive squamous carcinoma
TABLE 3
CYTOHISTOLOGIC CORRELATION OF EITHER PURE GLANDULAR INTRAEPITHELIAL LESION (GIL) OR A MIXED GIL/SQUAMOUS
ABNORMALITY
Cytology n
Histology
Pure Mixed
GIL I GIL II Total GIL I + CIN GIL II + CIN GIL + MIC Total
n n n (%) n n n n (%)
GIL I 4 4 4 (22.2)
GIL I + CIN 8 2 2 4 (22.2) 3 1 4 (11.8)
GIL II + CIN 5 1 1 (5.6) 1 3 4 (1.8)
AIS + CIN 4 2 2 (11.1) 1 1 2 (5.9)
GIL + MIC 2 1 1 2 (5.9)
CIN 24 1 1 2 (11.1) 8 10 4 22 (64.6)
Inflammation 5 3 2 5 (27.8)
Total 52 11 7 18 (100.0) 14 14 6 34 (100.0)
% (100.0) 34.6 65.4
GIL – glandular intraepithelial lesion, CIN – cervical intraepithelial neoplasia, AIS – adenocarcinoma in situ, MIC – microinvasive car-
cinoma
carcinoma significantly more rapidly than does CIS into
SCC, and this seems to be the case indeed35. It would
leave ample time for detection of glandular dysplasia, but
not necessarily of AIS36.
The prevalence of GIL is unknown; however, it is
much lower than that of SIL. Some authors report on the
AIS to SIL ratio of 1:10534. The rate of dysplasia of
endocervical columnar epithelium is 16-fold that of AIS34.
The ratio of in situ and invasive lesions is 1:3 for glandu-
lar and 5.25:1 for squamous lesions35. The latency period
between AIS and invasive adenocarcinoma is 13 years
compared with 18 years latency period between CIN and
invasive SCC35, allowing for ample time for screening for
preinvasive lesion.
Patients diagnosed with mild glandular lesions are by
some 10 years younger than those with invasive disea-
se37. The median age of patients in our study was 39.89
years (GIL-40.15; AIS-39.69), which is comparable to 41
years reported in the literature38 and slightly older than
the averages from other studies39,40. In a series of initial
cervical smear, minimal to severe atypia of columnar epi-
thelium was detected in 50% of cases with squamous epi-
thelial lesions10, pointing to common etiologic factors,
among them human papillomavirus (HPV) at the first
place.
A coexisting SIL may obscure glandular lesion be-
cause abnormalities involving exclusively the squamous
component were quite frequently observed in the latter,
either because of the more distinct criteria and easier
recognition, or due to more pronounced cellular lesions,
or because of the predominant population of abnormal
squamous cells, especially when extensive or high grade.
In our study, the incidence of coexisting squamous le-
sions was 74.8%, which is consistent with literature re-
ports on 41%–76.7%39,41.
The pre-conization diagnosis of AIS and GIL (I, II) is
challenging. Historically, only sporadic cases of AIS have
been reported since it was first defined by Friedell and
McKay in 195342, when they only described its histologic
appearance. In the 1970s and 1980s, descriptive studies
detailing the cytologic criteria necessary for the prospec-
tive cytologic diagnosis of AIS of uterine cervix were
published5,6,8, increasing the awareness and diagnostic
skill of cytologists. Papanicolaou smears may be less sen-
sitive than they are for squamous precursors because
AIS may mimic endometrial cells or reactive endocervical
cells11,43. Also, benign conditions such as tubal meta-
plasia and cervical endometriosis9 may cytologically mi-
mic AIS. There is overlap between the cytologic criteria
for various glandular lesions of the cervix, and there is an
increasing need for defining and recognizing both benign
and malignant cervical glandular lesions. In a number of
retrospective case series published within the last 15
years, screening of Papanicolaou smears detected glan-
dular abnormality before confirmation of AIS on cone bi-
opsy or hysterectomy in 32%–69% of cases8,32,39,44–47.
In our experience, the number of AIS cases we identi-
fied has increased with time after our first identification
in 1986. In our patients, Papanicolaou smear had a sensi-
tivity of 74.2% in detecting glandular abnormality preop-
eratively, while cytologic differential diagnosis of AIS and
GIL yielded a 61.5% and 22.2% accuracy, respectively,
similar to other reports3,8,39. Ioffe et al.3 demonstrated
the use of a semiquantitative system for the diagnosis of
noninvasive endocervical glandular lesions to result in
better diagnostic reproducibility even in diagnostically
problematic cases.
Conclusion
The cytodiagnosis of cervical columnar epithelial le-
sions lags behind the cytodiagnosis of squamous epithe-
lial lesions both in terms of screening and differential di-
agnosis. We believe that Papanicolaou smear that includes
adequate material from the transformation zone and en-
docervix can be useful method for detecting precursor le-
sions of adenocarcinoma of the cervix. As our under-
standing of glandular lesions continues to expand and
cervical sampling techniques continue to improve, we
may expect constant enhancement in our ability to de-
tect and treat intraepithelial glandular lesions and thus
help reduce the morbidity and mortality of cervical adeno-
carcinoma.
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CITOLOGIJA CERVIKALNIH INTRAEPITELNIH LEZIJA CILINDRI^NOG EPITELA
S A @ E T A K
Citolo{ki kriteriji za identifikaciju glandularnih intraepitelnih lezija jo{ nisu detaljno opisani, posebice za prekur-
sore adenokarcinoma in situ (AIS) te ove lezije ~esto nisu prepoznate. Ve}ina bolesnica u kojih je dijagnosticiran AIS ili
glandularna intraepitelna lezija (GIL) lakog i srednjeg stupnja su bez klini~kih simptoma te citologija ima vrlo od-
govorno mjesto u otkrivanju ovih lezija. U svrhu postizanja {to adekvatnije i to~nije citolo{ke dijagnoze intraepitelnih
lezija endocervikalnog cilindri~nog epitela, analizirani su citolo{ki nalazi bolesnica u kojih su histolo{ki verificirane
glandularne intraepitelne lezije. Vrijednost citologije u otkrivanju i u diferencijalnoj dijagnozi, uzimaju}i u obzir te`inu
lezije i/ili vrstu promjenjenog epitela, testirana je u 123 bolesnice s kona~nom histolo{kom dijagnozom intraepitelne
glandularne lezije AIS (n=13), GIL I (n=11), GIL II (n=7), odnosno glandularne lezije udru`ene s plo~astom kom-
ponentom AIS uz cervikalnu intraepitelnu leziju (CIN) i/ili invazivni karcinom plo~astog epitela (IC) (n=58), GIL I ili
GIL II+CIN (n=28), GIL uz mikroinvazivni plo~asti karcinom (MIC) (n=6) U 95,1% lezija je otkrivena citolo{kom
analizom koja je indicirala daljnju dijagnosti~ku obradu. Diferencijalno dijagnosti~ka to~nost citologije bila je vi{a u
predvi|anju te`ine lezije 75,6% nego vrste promjenjenog epitela 55,3% te u predskazivanju abnormalnosti plo~astog
95,7% za razliku od cilindri~nog epitela 74,2% To~nost citologije bila je ve}a za ~iste lezije (AIS – 61,5%; GIL I /GIL II –
22,2%) nego za mije{ane lezije (25,9% i 20,6%). Kontinuirano pobolj{anje cervikalnih razmaza i citodijagnosti~kih vje-
{tina, bolje razumijevanje i definiranje predstadija intraepitelnog adenokarcinoma i njihovo uklju~ivanje u citolo{ku i
patohistolo{ku klasifikaciju lezija vrata maternice, moralo bi rezultirati boljom detekcijom i dijagnostikom glandu-
larnih intraepitelnih lezija te smanjenjem morbiditeta i mortaliteta od invazivnog cervikalnog adenokarcinoma.
A. Ovanin-Raki} et al.: Cervical Intraepithelial Glandular Lesions Cytology, Coll. Antropol. 34 (2010) 2: 401–406
406
